Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Felvizumab [USAN:INN]
Description: A respiratory syncytial virus (RSV)-specific reshaped human monoclonal antibody (IgG1 framework) used for treatment or prophylaxis of human RSV infection. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Jul 2019